WallStreetZenWallStreetZen

NASDAQ: MGX
Metagenomi Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Metagenomi Therapeutics revenue was $25.21M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $3.9M, down 54.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MGX annual revenue was $25.2M, with -51.8% growth year-over-year.

MGX past revenue growth

How has MGX's revenue growth performed historically?

Company
-51.79%
Industry
469.74%
Market
90.22%
MGX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MGX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

MGX revenue history

Current Revenue
$25.2M
Current Earnings
-$87.9M
Current Profit Margin
-348.5%

Be the first to know when MGX announces revenue.

MGX Revenue History By Year

MGX Yearly RevenueMGX RevenueMGX ChangeMGX Revenue Growth
2025-12-31$25.21M-$27.09M-51.79%
2024-12-31$52.30M$7.54M+16.84%
2023-12-31$44.76M$27.56M+160.21%
2022-12-31$17.20M$16.96M+6,978.19%
2021-12-31$243.00kN/AN/A

1 of 1

Metagenomi Therapeutics Revenue FAQ

What was MGX's revenue last quarter?

Metagenomi Therapeutics (NASDAQ: MGX) reported Q4 2025 revenue of $3.91 million up 59.32% year over year. In the same quarter last year, Metagenomi Therapeutics's revenue was $9.61 million.

What was Metagenomi Therapeutics's revenue in 2025?

Metagenomi Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $25.21 million, a 51.79% decrease year over year.

How much does Metagenomi Therapeutics make in a day?

Based on Metagenomi Therapeutics annual revenue for the past four years, MGX makes an average of $95,521.23 per day.

What was Metagenomi Therapeutics's annual revenue growth in the past year?

As of Q1 2026, Metagenomi Therapeutics's revenue has grown -51.79% year over year. This is 521.53 percentage points lower than the US Biotechnology industry revenue growth rate of 469.74%. Metagenomi Therapeutics's revenue in the past year totaled $25.21 million.

How much does Metagenomi Therapeutics make in a year?

Metagenomi Therapeutics's revenue by year for the past four years is:
  • Metagenomi Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $25.21 million, a 51.79% decrease year over year.
  • Metagenomi Therapeutics's annual revenue for Dec 31, 2024 was $52.30 million, a 16.84% increase from 2023.
  • Metagenomi Therapeutics's annual revenue for 2023 was $44.76 million, a 160.21% increase from 2022.
  • Metagenomi Therapeutics's annual revenue for 2022 was $17.20 million, a 6,978.19% increase from 2021.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.